1[2]Nakakuki M,Yamasaki F,Shinkawa T,et al.Protective effect of human ulinastatln against gentamicin-induced acute renal failure in rats.Can-J-Physiol-Pharmacol,1996,74(1):104～111
2[3]Ueki M,Yokono S,Taie S,et al.Effects of ulinastatin on postoperative renal function in hepatectomized patients with liver cirrhosis.Masui,1997;46(2):251～255
3[4]Yokono S,Ueki M,Nakano M,et al.Urinary excretion of ulinastatin and NAG after cardiopulmonary bypass.Masui,1997,46(3):388～392
4[5]Hashimoto K,Nomura K,Nakano M,et al.Pharmacological intervention for renal protection during cardiopulmonary bypass.Heart-Vessels,1993,8(4): 203～210
5[6]Ueki M,Yokono S,Nogaya J,et al.Effects of ulinastatin on postoperativerenal function after cardiopulmonary bypass.Masui,1995,44(5):691～697
6[7]Cai M,Ogawa R.Effects of free radical scavengers,Methylprednisolone, and ulinastain on acute xanthine and xanthine oxidase-induced lung injury in rats.Circ-Shock,1994;43(2):71～78
7[8]Kondo D,Imaizumi M,Abe T.Study on extravascular lung water and polymorphonuclear leukocyte elastase during acute phase following radical treatment of lung cancer:effect of ulinastatin on respiratory functions.Kyobu-Geka,1993,46(11):922～925
8[9]Hiyama A,Takeda J,Kotake Y,et al.A human urinary protease inhibitor(ulinastatin) inhibits neutrophil extracellular release of elastase during cardiopulmonary bypass.J-Cardiothorac-Vasc-Anesth,1997,11(5):580～584
9[10]Miura M,Sugiura T,Aimi Y,et al. Effect of ulinastatin on PMNL and vascular endothelial injury in patients undergoing open heart surgery with CPB . Masui,1998,47(1):29～35
10[11]Watanabe A,Sumita S,Ichimiya T,et al.Effects of ulinastatin on extravascular lung water volume in patients undergoing Cardiopulmonary bypass. Masui,1994,43(1):78～88
